Clinical Trial Update: Clinical Evaluation Of The PARADYM RF Device [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical evaluation of the PARADYM RF device for heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: LivaNova | Conditions: Heart Failure | Phase 3 | Status: COMPLETED